Access to anti-retroviral drugs, male in Philippines
Philippines: Access to anti-retroviral drugs, male was 42.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, male in Philippines, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
In 2024, access to anti-retroviral drugs, male in Philippines stood at 42.0%.
That represents a change of up 2.4% on the previous year and up 133.3% over ten years.
Over the whole period, access to anti-retroviral drugs, male in Philippines peaked at 43.0% in 2022 and was at its lowest, 0.0%, in 2000.
Philippines ranks 128th of 141 countries on this measure, in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, male in Philippines, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 1.0% | — |
| 2006 | 2.0% | +100.0% |
| 2007 | 3.0% | +50.0% |
| 2008 | 3.0% | +0.0% |
| 2009 | 4.0% | +33.3% |
| 2010 | 5.0% | +25.0% |
| 2011 | 6.0% | +20.0% |
| 2012 | 8.0% | +33.3% |
| 2013 | 14.0% | +75.0% |
| 2014 | 18.0% | +28.6% |
| 2015 | 23.0% | +27.8% |
| 2016 | 28.0% | +21.7% |
| 2017 | 33.0% | +17.9% |
| 2018 | 38.0% | +15.2% |
| 2019 | 42.0% | +10.5% |
| 2020 | 40.0% | -4.8% |
| 2021 | 41.0% | +2.5% |
| 2022 | 43.0% | +4.9% |
| 2023 | 41.0% | -4.7% |
| 2024 | 42.0% | +2.4% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 1.3% | 0.0% | 4.0% | 10 |
| 2010s | 21.5% | 5.0% | 42.0% | 10 |
| 2020s | 41.4% | 40.0% | 43.0% | 5 |
Countries ranked near Philippines
More gender data for Philippines
- Child population (UN estimates and projections) 28,934 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -1.61 % change on previous year (2030)
- Population 92,475 (2030)
- Working-age population (UN estimates and projections) 92,475 (2030)
- Population (UN estimates and projections), annual growth rate 1.52 % change on previous year (2030)
- Age population, age 00, female, interpolated 871,613 (2025)
- Age population, age 00, male, interpolated 935,850 (2025)
- Age population, age 01, female, interpolated 864,989 (2025)
- Age population, age 01, male, interpolated 929,411 (2025)
- Age population, age 02, female, interpolated 858,439 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, male in Philippines?
- Access to anti-retroviral drugs, male in Philippines was 42.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, male recorded in Philippines?
- The highest recorded value was 43.0% in 2022.
- What is the lowest access to anti-retroviral drugs, male recorded in Philippines?
- The lowest recorded value was 0.0% in 2000.
- How does Philippines rank for access to anti-retroviral drugs, male?
- Philippines ranks 128th out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, male rising or falling in Philippines?
- Over the last ten years it is up 133.3%. The long-run trend across the full record is volatile.
- Where does this Philippines data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, male (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.